• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant Pharmaceuticals

Valeant Pharmaceuticals

Page 2 of 4
FinanceThis Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
By Laura LorenzettiMay 10, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
FinanceValeant Files Much Delayed Annual Earnings Saying It’s “Cured”
By Lucinda ShenApril 29, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceHere’s Why Valeant’s Shares Are Rising
By ReutersApril 7, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Hints Who Valeant’s Next CEO Will Be
By Jen WiecznerApril 6, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceHere’s Why Moody’s Just Downgraded Valeant
By Jen WiecznerApril 1, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Asked for Information in Drug Pricing Probe
By ReutersMarch 24, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceThe Really Big Problem with Valeant’s Billions of Debt
By Lauren Silva LaughlinMarch 22, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceHere’s Why Valeant May Have Accused Its Former CFO of “Improper Conduct”
By ReutersMarch 21, 2016
Drug Hearing
FinanceValeant Infighting Is Getting Nasty
By Jen WiecznerMarch 21, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceThis Valeant Investor Is In Even Bigger Trouble than Bill Ackman
By Jen WiecznerMarch 18, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceValeant CEO Promises Company Won’t Go Bankrupt in Staff Memo
By Jen WiecznerMarch 18, 2016
MSMB Capital Management CIO Martin Shkreli
FinanceEven Pharma Bro Martin Shkreli Wouldn’t Touch Valeant
By Lucinda ShenMarch 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant’s Shares Are Having An Epically Bad Day
By Jen WiecznerMarch 15, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
HealthValeant Just Slashed Its Profit Guidance
By Reuters and Fortune EditorsMarch 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceHere’s What Valeant’s Earnings Tell Us About the Future of the Drug Maker
By Jen WiecznerMarch 14, 2016
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents showAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartestAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Gen Z’s straight‑A boom is quietly shrinking their paychecksAn image of a popular article
By Fortune EditorsMarch 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.